Antibiotic therapy of aortic graft infection: Treatment and prevention recommendations

Seminars in Vascular Surgery

Volumn 24, Issue 4, 2011, Pages 191-198

  Hodgkiss Harlow, Kelley D ^a   Bandyk, Dennis F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN; DAPTOMYCIN; LINEZOLID; PLACEBO; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ABSCESS DRAINAGE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; AORTA GRAFT; AORTOFEMORAL BYPASS; ARTERY RECONSTRUCTION; ARTICLE; BACTERIAL COLONIZATION; CANDIDA ALBICANS; DEBRIDEMENT; DIABETES MELLITUS; DRUG EFFICACY; ESCHERICHIA COLI; EXCISION; FEMOROFEMORAL BYPASS; GRAFT INFECTION; GRAM POSITIVE BACTERIUM; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; KLEBSIELLA PNEUMONIAE; LIMB PERFUSION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; RISK REDUCTION; SINGLE DRUG DOSE; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; SURGICAL INFECTION; VEIN RECONSTRUCTION; WOUND CARE; WOUND CLOSURE; WOUND DRESSING;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; AORTA; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CROSS INFECTION; DEVICE REMOVAL; DRUG RESISTANCE, BACTERIAL; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; REOPERATION; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84855502254     PISSN: 08957967     EISSN: 15584518     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2011.10.013     Document Type: Article

References (16)

1. Culver D.H., Horan T.C., Gaynes R.P., et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 1991, 91(suppl 3B):153S.
2. Bandyk D.F. Vascular surgical site infection: risks factors and prevention. Semin Vasc Surg 2008, 21:119-123.
3. Vogel T.R., Symons R., Flum D.R. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008, 47:264-269.
4. National Nosocomial Infectious Surveillance (NNIS) System Report, data summary from January 1992 thru October 2004. Am J Infect Control 2004, 32:470-485. National Nosocomial Infectious Surveillance System.
5. Bandyk D.F., Novotney M., Johnson B.L., et al. Use of rifampin soaked gelatin sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J Surg Res 2001, 95:44-49.
6. Bandyk D.F., Novotney M., Johnson B.L., et al. Expanded application of in situ replacement for infected vascular grafts. J Vasc Surg 2001, 34:411-420.
7. Stone P.A., Armstrong P.A., Bandyk D.F., et al. Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic graft infections. J Vasc Surg 2006, 44:757-761.
8. Armstrong P.A., Back M.R., Bandyk D.F., et al. Selective application of sartorius muscle flap and aggressive staged surgical debridement can influence long-term outcomes of complex graft infections. J Vasc Surg 2007, 46:71-78.
9. Pounds L.L., Montes-Walters M., Mayhall C.G., et al. A changing pattern of infection after major vascular reconstructions. Vasc Endovasc Surg 2005, 39:511-517.
10. Meakins J.L., Masterson B.J. Prevention of postoperative infection. ACS Surgery: Principles and Practice 2005, 1-19. WebMD, Inc., Atlanta, GA. W.E. Suba (Ed.).
11. Cowie S.E., Ma I., Lee S.K., et al. Nosocomial MRSA infection in vascular patients: impact on patient outcome. Vasc Endovasc Surg 2005, 39:327-334.
12. Perl T.M., Cullen J.J., Wenzel R.P., et al. The mupirocin and the risk of Staphylococcus aureus study team: intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002, 346:1987.
13. Bandyk D.F. Antibiotics-why so many and when should we use them?. Semin Vasc Surg 2002, 15:268-274.
14. Harbarth S., Fankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149-1157.
15. Grief R., Akca O., Horn E.P., et al. Supplemental perioperative oxygen to reduce of surgical-wound infection. N Engl J Med 2000, 342:161-167. Outcomes Research Group.
16. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999, 20:250. Accessed August 10, 2011. http://www.cdc.gov/ncidod/dhqp/gl_surgicalsite.html.